Connecticut Colleges CT

'Paradigm-shifting' treatment for pediatric diabetes cleared by FDA

Yale University

Jun 25, 2026

'Paradigm-shifting' treatment for pediatric diabetes cleared by FDA

Yale's Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab - recently approved for pediatric patients with Stage 3 Type 1 diabetes -…

Read the full story at Yale University

Topics

#Yale University

'Paradigm-shifting' treatment for pediatric diabetes cleared by FDA

Topics

More from Connecticut Colleges

Yale Center for Civic Thought explores when to compromise, when to stand your ground

'The Marcela effect': Women Faculty Forum honors leader in health care equity

An astrophysicist and a musician on waves

Religious Preschools Want Public Funding, but Exemptions from Non-Discrimination Rules. Now the Supreme Court Will Decide If That's Constitutional

Using Math and Science to Tell a Story, Engineering Student Adds in Some Magic Too

Thanking Nurses With a DAISY

Study helps explain why changing your diet is hard

From Southern to the Stage: Remembering Darik Pearson, '94